Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

The committee reviewed data showing a 94 percent complete response rate as a third- or later-line treatment for refractory follicular lymphoma.

People attending a football match will be asked to sign up to a stem cell register in the hope of finding a donor for a local ...

Bristol Myers (BMY) announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has ...

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

Serum soluble interleukin-2 receptor (sIL-2R) levels have been a great diagnostic tool for non-Hodgkin lymphoma (NHL) and ...

Patients were stratified by CD30 expression (positive [≥1%] v negative [<1%]), cell of origin (germinal center B cell or non–germinal center B cell), previous treatment with CAR T-cell therapy ...

During a recent interview with ABC WXYZ in Detroit, Dave Coulier's wife, Melissa, said that while the “Full House" alum's ...

Dave Coulier has been open about his battle with cancer since he went public with his diagnosis in November 2024 ...